EUVIMEDEUVIMED entdecken
Crossref

Effects of selenium supplementation on cognitive function in patients with hyperthyroidism caused by Graves’ disease: A randomized prospective study

Jianli Huang iD, Li Liu iD, Wenfu Tao iD, Jiayu Luo iD, Jinyue Meng iD, Yuanyuan Lin iD, Guangjing Huang iD, Hui Wei iD, Xuemei Huang iD

Journal of Investigative Medicine · 07.10.2026

DOI: 10.1177/10815589261497366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Investigative Medicine, online erschienen am 07.10.2026. Verfasst von Jianli Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Nanning Qingxiu District Science and Technology Plan Project, Natural Science Foundation of Guangxi Zhuang Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The study investigated the effects of selenium supplementation on cognitive function in patients with Graves’ hyperthyroidism.

Methods

A total of 124 newly diagnosed patients with Graves’ hyperthyroidism and with a baseline Montreal Cognitive Assessment (MoCA) score < 26 were recruited. Participants were randomly assigned to either the conventional treatment group ( n = 62) or the combined treatment group ( n = 62). Cognitive and biochemical assessments were conducted at baseline and at 4, 8, and 12 weeks post-intervention. The primary outcomes were MoCA score and blood selenium concentration. Secondary outcomes included total triiodothyronine (TT3), total thyroxine (TT4), free triiodothyronine (FT3), free thyroxine (FT4), thyroid-stimulating hormone (TSH) and thyrotropin receptor antibodies (TRAb).

Results

At the 4th, 8th, and 12th weeks of follow-up, the MoCA scores, blood selenium concentrations and TSH levels in the combined treatment group were significantly higher than those in the conventional treatment group (all p < 0.05), whereas TRAb levels were significantly lower ( p < 0.05). Linear mixed-effects modeling revealed statistically significant group × time interactions for MoCA scores (β = 1.914, 95% CI: 1.152–2.018, p = 0.012), blood selenium concentrations (β = 21.132, 95% CI: 18.302–30.171, p < 0.001), TRAb levels (β = −3.286, 95% CI: −5.575 to −1.120, p < 0.001) and TSH levels (β = 1.136, 95% CI: 0.812–1.398, p < 0.001). Linear correlation analysis demonstrated that changes in blood selenium concentrations from baseline to at week 12 were moderately positively correlated with changes in MoCA scores ( r = 0.538, p < 0.001), moderately negatively correlated with changes in FT4 levels ( r = −0.437, p < 0.001), and strongly negatively correlated with changes in TRAb levels ( r = −0.722, p < 0.001). Partial correlation analysis confirmed that changes in blood selenium concentrations remained significantly negatively associated with changes in TRAb levels ( r = −0.690, p < 0.001). Furthermore, binary logistic regression analysis indicated that improvement in cognitive function among patients with Graves’ hyperthyroidism was significantly associated with treatment modality (OR = 0.046, 95% CI: 0.017–0.123, p < 0.001).

Conclusion

Selenium supplementation therapy confers significant cognitive benefits in patients with Graves’ hyperthyroidism.

Trial registration

The study was registered with the Chinese Clinical Trial Registry ( https://www.chictr.org.cn/ , No. ChiCTR 2400092543)

Schlagwörter

Stichwörter der Autor:innen

Graves’ diseasecognitive functionhyperthyroidismmethimazoleselenium

Autor:innen und Institutionen

  • Department of Endocrinology, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Department of Endocrinology, The First People's Hospital of Nanning, Nanning, Guangxi, China.
  • Department of Clinical Laboratory, The First People's Hospital of Nanning, Nanning, Guangxi, China.

ORCID-Profile: Jianli Huang, Li Liu, Wenfu Tao, Jiayu Luo, Jinyue Meng, Yuanyuan Lin, Guangjing Huang, Hui Wei, Xuemei Huang

Förderung

  • Nanning Qingxiu District Science and Technology Plan Project
  • Natural Science Foundation of Guangxi Zhuang Autonomous Region

Zitieren

APA

Huang, J., Liu, L., Tao, W., Luo, J., Meng, J., Lin, Y., Huang, G., Wei, H., & Huang, X. (2026). Effects of selenium supplementation on cognitive function in patients with hyperthyroidism caused by Graves’ disease: A randomized prospective study. Journal of Investigative Medicine. https://doi.org/10.1177/10815589261497366

Vancouver

Huang J, Liu L, Tao W, Luo J, Meng J, Lin Y, et al. Effects of selenium supplementation on cognitive function in patients with hyperthyroidism caused by Graves’ disease: A randomized prospective study. Journal of Investigative Medicine. 2026. doi:10.1177/10815589261497366

BibTeX
@article{Huang2026,
  author = {Huang, Jianli and Liu, Li and Tao, Wenfu and Luo, Jiayu and Meng, Jinyue and Lin, Yuanyuan and Huang, Guangjing and Wei, Hui and Huang, Xuemei},
  title = {Effects of selenium supplementation on cognitive function in patients with hyperthyroidism caused by Graves’ disease: A randomized prospective study},
  journal = {Journal of Investigative Medicine},
  year = {2026},
  doi = {10.1177/10815589261497366}
}
Kostenlos starten →